Invesco Ltd. research snapshot

IVZ AI Stock Analysis

IVZ AI stock analysis currently reads Invesco as a cyclical asset manager in a clearly improving phase rather than a simple compounder. The company reported Q2 2026 adjusted diluted EPS of $0.71, record net long-term inflows of $45.1 billion, and ending AUM of $2.47 trillion as of June 30, 2026, with adjusted operating margin expanding to 37.5% and net debt falling to $708.6 million. The scenario forecast is positive but not extreme: strong flows, QQQ economics, and margin expansion support the bull case, while fee pressure, market beta, leverage, preferred stock, and active product outflows keep investment certainty moderate. This page is for informational research only and is not investment advice.

Current price

$29.60

Market cap

$13.07 billion verified by price times Q2 2026 shares

AI score

67 / 100

Rating

Improving asset manager with record flows, deleveraging, and a still reasonable valuation

Trend status

Constructive uptrend, price above the 50-day and 200-day moving averages after a Q2 2026 earnings beat

Data cutoff (updated monthly)

August 4, 2026

Informational use only. This page is not investment advice.

Research quality check

information Richness
A-level information richness. IVZ has long public trading history, SEC filings, detailed Invesco earnings releases, monthly AUM releases, proxy materials, and broad third-party financial and technical coverage.
bias Check
The main AI bias risk is over-weighting the visible AUM recovery, record inflows, and Q2 beat while under-weighting the hard parts: asset managers are cyclical, fee rates can compress, active strategies can lose share, and GAAP earnings are still distorted by impairment and consolidation charges.
ai Confidence
High for reported Q2 2026 operating revenue, adjusted EPS, ending AUM, cash, debt, share count, and price-based market cap math. Medium for forward returns because equity markets, flows, fee mix, and valuation multiples change quickly.
investment Certainty
Medium-low to medium, improved from earlier in 2026. The franchise now combines scale, record organic growth, margin expansion, and a cleaner balance sheet, but the stock still depends on sustained flows, market levels, expense control, and investor confidence in adjusted rather than GAAP earnings.

Quick verdict table

DimensionConclusionConfidence
Business qualityInvesco earns fees from ETFs, active equity, fixed income, alternatives, money market, model portfolios, and institutional mandates, with revenue tied to AUM levels and product mix.Medium-high
MoatThe moat is strongest in QQQ, ETF distribution, global platform breadth, fixed income capability, and advisor relationships, but weaker in commoditized active products.Medium
ManagementAndrew Schlossberg has executed simplification, QQQ conversion to an open-end fund ETF, private markets partnerships, net debt reduction of more than $450 million in Q2 2026, and a return to buybacks.Medium-high
Financial trendQ2 2026 operating revenue was $1.826 billion, adjusted EPS was $0.71, ending AUM was $2.47 trillion, adjusted operating margin was 37.5%, and net debt fell to $708.6 million.High
ValuationAt $29.60 and forward EPS near $3.01 implied by the 9.85x forward PE, IVZ screens at roughly 9.85x forward earnings, 1.05x book value, and a 14.73% free cash flow yield using StockAnalysis per-share data.Medium
Technical trendThe tape is constructive: IVZ closed at $29.60 on July 31, 2026, above the 20-day, 50-day, 100-day, and 200-day moving averages, with 14-day RSI near 54.75.Medium-high
Risk levelMain risks are market drawdowns, outflows, fee compression, debt and preferred stock burden, active manager underperformance, regulation, and expense inflation.Medium-high
AI confidenceDescriptive confidence is high because filings and market data are available. Forecast confidence is lower because IVZ is highly sensitive to markets and flows.High data confidence
Investment certaintyThe stock can work if AUM, QQQ revenue, margins, and capital returns keep improving, and the Q2 2026 record is supportive, but IVZ is still not a high certainty compounder at any price.Medium-low

IVZ AI stock forecast

IVZ AI Stock Forecast Scenarios

The IVZ AI stock forecast uses scenario math around the $29.60 July 31, 2026 price reference, forward EPS near $3.01 implied by the 9.85x forward PE, and a three-year earnings multiple framework. The audited model produced a bearish area near $24.70, a base area near $38.30, and a bullish area near $52.10 before dividends.

Bullish case

$44 to $52

More likely if Q2 2026 record inflow momentum persists, QQQ and ETF economics lift net revenue yield, adjusted operating margin stays near 37.5%, leverage stays low, and the market assigns IVZ a 12x to 13x earnings multiple.

Base case

$33 to $40

More likely if adjusted EPS grows modestly, AUM stays near current levels, buybacks continue to offset dilution, fee pressure remains manageable, and IVZ trades near a 10x to 11x earnings multiple.

Bearish case

$22 to $27

More likely if markets weaken, net flows reverse, QQQ revenue benefit disappoints, adjusted margins compress, or investors discount adjusted earnings more heavily after the record growth period.

IVZ AI technical analysis

IVZ AI Technical Analysis

IVZ AI technical analysis is constructive as of the August 2, 2026 cutoff. StockAnalysis showed IVZ at $29.60 at the July 31, 2026 close, up 37.80% over 52 weeks. Barchart listed the 5-day moving average at $29.33, 20-day at $29.19, 50-day at $28.20, 100-day at $26.59, and 200-day at $26.14, with 14-day relative strength near 54.75 and 14-day ADX near 20.67 with +DI above -DI.

LevelValueWhy it matters
Current price$29.60StockAnalysis July 31, 2026 market close used for the price reference.
Immediate support$29.19Barchart lists the 20-day moving average near $29.19, and the 5-day average sits near $29.33, forming a short-term support cluster.
50-day moving average$28.20Both Barchart and StockAnalysis place the 50-day average near $28.20, a useful short to medium-term trend marker.
200-day moving average$26.14Both feeds agree on the 200-day average near $26.14, now clearly below price, which supports the longer-term uptrend.
Near resistance$30.00 to $31.02StockAnalysis lists the 52-week high near $31.02. A sustained move through that area would confirm stronger demand.
MomentumRSI near 54.75Barchart shows neutral to mildly bullish momentum rather than an overbought extreme, with ADX near 20.67 and +DI above -DI.
Volume and volatilityAverage volume near 5.0 million, 14-day ATR near $1.00Barchart shows active liquidity, roughly 3.4% two-week average true range as a percent of price, and 14-day historic volatility near 40.9%.
InvalidationClose below $28.20A close below the 50-day moving average would weaken the recovery setup and shift focus to the 100-day and 200-day averages near $26.59 and $26.14.

IVZ AI trading strategy

IVZ AI Trading Strategy Framework

The IVZ AI trading strategy below is a rules-based research framework, not personalized advice. It combines market regime, AUM trend, fund flows, QQQ economics, capital return, deleveraging, and technical confirmation.

Trend-following setup

Watch for IVZ to hold above the $29.19 to $29.33 cluster and then clear $30.00 to $31.02 with continued record net long-term inflows, positive AUM releases, margin expansion, and stable expense guidance.

A failed breakout back below the 20-day average or a close below $28.20 should reduce setup confidence.

Mean-reversion setup

If IVZ pulls back toward $28.20 to $29.19 without a new market drawdown or flow shock, compare price behavior with AUM releases, ETF demand, fixed income flows, and credit spreads.

Do not average down if broad markets are falling, active outflows accelerate, or debt and preferred capital concerns return.

Fundamental monitor

Track monthly AUM, net long-term flows, QQQ revenue contribution, adjusted operating margin, net debt, cash, preferred stock balance, buybacks, dividend coverage, and active fund performance.

Position sizing should reflect that IVZ is partly a levered expression of markets, flows, and investor appetite for asset manager equities.

Investment research summary

Four-master Research Compression

Business essence

Invesco sells investment access, portfolio management, ETF exposure, active strategies, fixed income products, alternatives, and institutional solutions. Clients pay for distribution, product choice, brand trust, and investment process.

Moat

The moat is narrow to moderate overall. QQQ and ETF distribution have stronger brand and scale advantages, while many active strategies face substitutable products, fee pressure, and performance-sensitive flows.

Munger risk inversion

The thesis fails if markets fall, clients redeem, active performance disappoints, fee rates keep compressing, QQQ benefits are offset by costs, or debt and preferred stock limit capital returns after the recent deleveraging.

Management

Andrew Schlossberg has delivered on focus, scale, balance sheet repair, QQQ modernization, record inflows, and margin expansion. The execution test is whether those moves convert higher AUM into durable per-share earnings through market cycles.

Industry trend

Asset management benefits from retirement savings, ETF adoption, model portfolios, alternatives, and global wealth growth. The offset is that passive products pressure fees and weak markets can reverse AUM quickly.

Valuation and margin of safety

IVZ screens inexpensive on forward earnings, book value, dividend yield, and FCF yield, but that valuation still partly reflects cyclicality, impairment history, leverage, and lower confidence in normalized earnings.

Source-backed data

IVZ Data Table

Every metric below includes a source and last verification date.

MetricValueSourceLast verified
IVZ price reference$29.60 at July 31, 2026 closeStockAnalysisAugust 2, 2026
Market capitalization$13.07 billion calculated from $29.60 price and 441.5 million Q2 2026 sharesPineify financial_rigor.py using Invesco Q2 2026 share countAugust 2, 2026
Q2 2026 operating revenues$1,825.6 millionInvesco Q2 2026 ResultsAugust 2, 2026
Q2 2026 adjusted diluted EPS$0.71, up 24.6% quarter over quarter and 97.2% year over yearInvesco Q2 2026 ResultsAugust 2, 2026
Q2 2026 ending AUM$2,470.3 billion, up 14.4% from Q1 2026Invesco Q2 2026 ResultsAugust 2, 2026
Q2 2026 adjusted operating margin37.5%, up 3 percentage points quarter over quarterInvesco Q2 2026 ResultsAugust 2, 2026
Q2 2026 net long-term inflows$45.1 billion, a quarterly recordInvesco Q2 2026 ResultsAugust 2, 2026
Q2 2026 cash, debt, and net debt$915.4 million cash, $1,624.0 million debt, $708.6 million net debtInvesco Q2 2026 ResultsAugust 2, 2026
Q2 2026 common shares outstanding441.5 millionInvesco Q2 2026 ResultsAugust 2, 2026
June 30, 2026 preliminary AUM$2,470.3 billionInvesco Corporate AUM releaseAugust 2, 2026
Valuation ratiosForward PE 9.85, PB 1.05, P/FCF 6.79, FCF yield 14.73%, dividend yield 2.91%StockAnalysis statisticsAugust 2, 2026
Per-share valuation inputsBVPS $28.25, FCF per share $4.36, dividend per share $0.86StockAnalysis statisticsAugust 2, 2026
Technical indicatorsRSI 54.75, 50-day MA $28.20, 200-day MA $26.14, 52-week change +37.80%StockAnalysis statistics and BarchartAugust 2, 2026
Moving averages and ATR5-day MA $29.33, 20-day MA $29.19, 50-day MA $28.20, 100-day MA $26.59, 200-day MA $26.14, 14-day ATR $1.00BarchartAugust 2, 2026

Frequently Asked Questions

This IVZ AI stock analysis is an informational research tool, not investment advice, a recommendation, or a guarantee of future returns. Forecast scenarios are based on available public data as of August 2, 2026 and may be wrong if markets, AUM, flows, fees, earnings, leverage, or valuation multiples change.